GB2153670B - A stable pharmaceutical composition for treating ketosis containing propylene glycol - Google Patents

A stable pharmaceutical composition for treating ketosis containing propylene glycol

Info

Publication number
GB2153670B
GB2153670B GB08500143A GB8500143A GB2153670B GB 2153670 B GB2153670 B GB 2153670B GB 08500143 A GB08500143 A GB 08500143A GB 8500143 A GB8500143 A GB 8500143A GB 2153670 B GB2153670 B GB 2153670B
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical composition
propylene glycol
stable pharmaceutical
containing propylene
treating ketosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB08500143A
Other versions
GB8500143D0 (en
GB2153670A (en
Inventor
Karoly Magyar
Ferenc Simon
Denes Bezzegh
Jozsef Kelemen
Gabor Zalai
Attila Mislei
Peter Sarkozi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Egyt Gyogyszervegyeszeti Gyar
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of GB8500143D0 publication Critical patent/GB8500143D0/en
Publication of GB2153670A publication Critical patent/GB2153670A/en
Application granted granted Critical
Publication of GB2153670B publication Critical patent/GB2153670B/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Obesity (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Fodder In General (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
GB08500143A 1984-01-06 1985-01-04 A stable pharmaceutical composition for treating ketosis containing propylene glycol Expired GB2153670B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU8440A HU191245B (en) 1984-01-06 1984-01-06 Process for the production of stbale pharmaceutical preparation against ketosis

Publications (3)

Publication Number Publication Date
GB8500143D0 GB8500143D0 (en) 1985-02-13
GB2153670A GB2153670A (en) 1985-08-29
GB2153670B true GB2153670B (en) 1988-03-23

Family

ID=10947613

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08500143A Expired GB2153670B (en) 1984-01-06 1985-01-04 A stable pharmaceutical composition for treating ketosis containing propylene glycol

Country Status (6)

Country Link
JP (1) JPS60214747A (en)
BE (1) BE901433A (en)
DE (1) DE3500187A1 (en)
FR (1) FR2565105B1 (en)
GB (1) GB2153670B (en)
HU (1) HU191245B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2202742B (en) * 1987-03-26 1990-11-28 Univ London Preventing adp-ribosylation of g-proteins
AU643703B2 (en) * 1989-09-15 1993-11-25 Cima Labs, Inc. Magnesium carbonate and oil tableting aid
US5601836A (en) * 1993-06-28 1997-02-11 Great Lakes Biochemical Company, Inc. Nutritional supplement for calving ruminant animals
GB9418420D0 (en) * 1994-09-13 1994-11-02 Mckeown Neil A Composition for the treatment of an energy imbalance in ruminents
US5560920A (en) * 1995-04-07 1996-10-01 The United States Of America, As Represented By The Secretary Of Agriculture Calcium formulations for prevention of parturient hypocalcemia
ATE242978T1 (en) 1997-03-21 2003-07-15 Basf Ag SOLUTIONS OF PROPIONIC ACID, AMMONIA, PROPANE DIOL AND WATER AND THEIR USE
US6126986A (en) * 1999-02-23 2000-10-03 Westway Trading Corporation Process for formulating a liquid animal feed ingredient containing sugar and neutralized carboxylic acid
CN104922064B (en) * 2015-05-28 2019-01-29 广东温氏大华农生物科技有限公司 A kind of nanoscale nutrient microemulsion and preparation method thereof for preventing and treating ketosis of dairy cows

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE156999C (en) * 1902-04-02
US3196073A (en) * 1961-03-16 1965-07-20 Dow Chemical Co Method of tranquilizing with 1, 2-dihydroxy propane
FR1546819A (en) * 1967-01-14 1968-11-22 Union Agricole Ag Fuer Landw S Process for supplemental feeding of high-yield dairy cows, in particular before and after calving, and supplemental feed for the implementation of the process
US3621163A (en) * 1970-01-19 1971-11-16 Acb Corp Inertia switch
DE2014844C2 (en) * 1970-03-26 1984-09-06 Boliden Ab, Stockholm Process for the manufacture of a granulated magnesium oxide product
DE2518189A1 (en) * 1975-04-24 1976-11-04 Astra Ewos Ab Trace element concentrate for animal feeds - heavy mineral substance coated with binder which contains trace elements
SE421042B (en) * 1976-06-29 1981-11-23 Kockums Chem WANT TO REDUCE THE QUANTITY OF BIOLOGICAL ACTIVE SUBSTANCE REQUIRED FOR SOME BIOLOGICAL EFFECT
JPS5344636A (en) * 1976-10-05 1978-04-21 Mitsubishi Chem Ind Ltd Remedy and prevention for milk fever
GB1596505A (en) * 1976-11-23 1981-08-26 Unilever Ltd Food manufacture
DE3010250A1 (en) * 1980-03-17 1981-09-24 Wolf Freiherr von 8183 Rottach-Egern Tucher Animal e.g. pig feed pre:concentrate - to reduce odour of animal excrement contg. a poly:hydric alcohol, a saturated fatty acid and a carrier
AT372854B (en) * 1981-02-03 1983-11-25 Moser Siegfried Dr METHOD FOR PREVENTING THE DEVELOPMENT OF ENGRAVING HEALTH INTERFERENCE IN RETURNS AND FOR PREVENTING DEER BITE
US4486412A (en) * 1983-03-15 1984-12-04 Pharmacaps, Inc. Encapsulated antacid dispersions
HU191244B (en) * 1984-01-06 1987-01-28 Egyt Gyogyszervegyeszeti Gyar Dust mixture of high propylene-glycol content and process for producing same
HU190866B (en) * 1984-01-06 1986-11-28 Egis Gyogyszergyar,Hu Process for producing concentratum increasing the weight output and containing agent of 1-25 mass pct. and/or animal food containing agent of 0,001-0,075 mass pct.

Also Published As

Publication number Publication date
GB8500143D0 (en) 1985-02-13
HUT37336A (en) 1985-12-28
FR2565105B1 (en) 1988-07-01
JPH0324450B2 (en) 1991-04-03
JPS60214747A (en) 1985-10-28
FR2565105A1 (en) 1985-12-06
GB2153670A (en) 1985-08-29
HU191245B (en) 1987-01-28
DE3500187A1 (en) 1985-07-18
BE901433A (en) 1985-07-03

Similar Documents

Publication Publication Date Title
EG17210A (en) Capsules for medicaments
GB2153678B (en) Pharmaceutical composition
GB8413191D0 (en) Pharmaceutical composition
DE3571549D1 (en) Pharmaceutical composition containing a hydroxypyrone-iron complex
EP0180364A3 (en) Pharmaceutical compositions containing phenothiazines
IL77138A0 (en) Pharmaceutical compositions containing 1-heteroaryl-4-arylpyrazolin-5-ones
ZA859731B (en) Pharmaceutical compositions containing tetrahydrobenzthiazoles
GB2153677B (en) Pharmaceutical composition
GB2153670B (en) A stable pharmaceutical composition for treating ketosis containing propylene glycol
ZA83130B (en) A pharmaceutical composition
GB8513641D0 (en) Pharmaceutical composition
AU92603S (en) Dose container
DE3368385D1 (en) Pharmaceutical composition having a cystostatic activity
ZA855365B (en) Pharmaceutical formulations for ceftazidime
GB8529160D0 (en) Pharmaceutical compounds
IL79195A0 (en) Pharmaceutical compositions containing a styrylnaphthalene derivative
GB2153676B (en) Pharmaceutical composition
GB8518565D0 (en) Pharmaceutical composition
IL79194A0 (en) Pharmaceutical compositions containing a styrylnaphthalene derivative
GB8726328D0 (en) Pharmaceutical compounds
GB8412503D0 (en) Pharmaceutical compounds
IL91357A0 (en) Pharmaceutical formulations containing certain benzimi-azolylmethyl benzenamides
IE840388L (en) Pharmaceutical compositions containing imidiazole¹derivatives
IE840541L (en) Pharmaceutical compositions containing rifampicin
GB8424513D0 (en) Pharmaceutical composition

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19970104